New mammogram tech could spot hidden breast cancers in dense tissue

NCT ID NCT05667532

First seen Jun 24, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study is testing whether contrast-enhanced mammography (CEM) can find breast cancers better than standard mammography in women with dense breasts. Dense breast tissue can hide tumors on regular mammograms, so better imaging is needed. Researchers will enroll 1,000 women aged 30–75 with dense breasts to compare the two methods. The goal is to see if CEM improves cancer detection and risk assessment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Contrast-Enhanced Mammography (CEM)
What this could lead to
If successful, CEM could become a more accurate screening tool for women with dense breasts, catching cancers earlier and reducing false alarms.
What could go wrong
This is an observational screening study, not a treatment trial. CEM may not prove significantly better than standard mammography, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.